Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Vaccine development for protecting swine against influenza virus.

Chen Q, Madson D, Miller CL, Harris DL.

Anim Health Res Rev. 2012 Dec;13(2):181-95. doi: 10.1017/S1466252312000175. Review.

PMID:
23253165
2.

Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v.

Kitikoon P, Gauger PC, Anderson TK, Culhane MR, Swenson S, Loving CL, Perez DR, Vincent AL.

Influenza Other Respir Viruses. 2013 Dec;7 Suppl 4:32-41. doi: 10.1111/irv.12189.

3.

Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.

Pena L, Vincent AL, Ye J, Ciacci-Zanella JR, Angel M, Lorusso A, Gauger PC, Janke BH, Loving CL, Perez DR.

J Virol. 2011 Jan;85(1):456-69. doi: 10.1128/JVI.01503-10. Epub 2010 Oct 20.

4.

Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.

Xu J, Yang D, Huang D, Xu J, Liu S, Lin H, Zhu H, Liu B, Lu C.

Arch Virol. 2013 Mar;158(3):629-37. doi: 10.1007/s00705-012-1539-9. Epub 2012 Nov 8.

PMID:
23135159
5.

Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.

Loeffen WL, Stockhofe N, Weesendorp E, van Zoelen-Bos D, Heutink R, Quak S, Goovaerts D, Heldens JG, Maas R, Moormann RJ, Koch G.

Vet Microbiol. 2011 Sep 28;152(3-4):304-14. doi: 10.1016/j.vetmic.2011.05.027. Epub 2011 May 24.

PMID:
21664078
6.

Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.

Thomas M, Wang Z, Sreenivasan CC, Hause BM, Gourapura J Renukaradhya, Li F, Francis DH, Kaushik RS, Khatri M.

Vaccine. 2015 Jan 15;33(4):542-8. doi: 10.1016/j.vaccine.2014.11.034. Epub 2014 Nov 28.

PMID:
25437101
7.

A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.

Bragstad K, Vinner L, Hansen MS, Nielsen J, Fomsgaard A.

Vaccine. 2013 Apr 26;31(18):2281-8. doi: 10.1016/j.vaccine.2013.02.061. Epub 2013 Mar 13.

PMID:
23499598
8.

Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.

Richt JA, Lekcharoensuk P, Lager KM, Vincent AL, Loiacono CM, Janke BH, Wu WH, Yoon KJ, Webby RJ, Solórzano A, García-Sastre A.

J Virol. 2006 Nov;80(22):11009-18. Epub 2006 Aug 30.

9.

DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.

Gorres JP, Lager KM, Kong WP, Royals M, Todd JP, Vincent AL, Wei CJ, Loving CL, Zanella EL, Janke B, Kehrli ME Jr, Nabel GJ, Rao SS.

Clin Vaccine Immunol. 2011 Nov;18(11):1987-95. doi: 10.1128/CVI.05171-11. Epub 2011 Sep 14.

10.

Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.

Vincent AL, Ma W, Lager KM, Janke BH, Webby RJ, García-Sastre A, Richt JA.

Vaccine. 2007 Nov 19;25(47):7999-8009. Epub 2007 Sep 29.

11.

Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.

Rajão DS, Chen H, Perez DR, Sandbulte MR, Gauger PC, Loving CL, Shanks GD, Vincent A.

J Gen Virol. 2016 Jul;97(7):1489-99. doi: 10.1099/jgv.0.000468. Epub 2016 Mar 31.

PMID:
27031847
12.

Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.

Souza CK, Rajão DS, Loving CL, Gauger PC, Pérez DR, Vincent AL.

Clin Vaccine Immunol. 2016 Jun 6;23(6):470-82. doi: 10.1128/CVI.00563-15. Print 2016 Jun.

13.

Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.

Masic A, Lu X, Li J, Mutwiri GK, Babiuk LA, Brown EG, Zhou Y.

Vaccine. 2010 Oct 8;28(43):7098-108. doi: 10.1016/j.vaccine.2010.08.003. Epub 2010 Aug 12.

PMID:
20708697
14.

Swine influenza virus vaccines: to change or not to change-that's the question.

Van Reeth K, Ma W.

Curr Top Microbiol Immunol. 2013;370:173-200. doi: 10.1007/82_2012_266. Review.

PMID:
22976350
15.

Divergent immune responses and disease outcomes in piglets immunized with inactivated and attenuated H3N2 swine influenza vaccines in the presence of maternally-derived antibodies.

Sandbulte MR, Platt R, Roth JA, Henningson JN, Gibson KA, Rajão DS, Loving CL, Vincent AL.

Virology. 2014 Sep;464-465:45-54. doi: 10.1016/j.virol.2014.06.027. Epub 2014 Jul 18.

16.
17.
18.

Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.

Wen F, Yu H, Yang FR, Huang M, Yang S, Zhou YJ, Li ZJ, Tong GZ.

Arch Virol. 2014 Nov;159(11):2957-67. doi: 10.1007/s00705-014-2151-y. Epub 2014 Jun 24.

PMID:
24957653
19.

Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.

Hughes HR, Vincent AL, Brockmeier SL, Gauger PC, Pena L, Santos J, Braucher DR, Perez DR, Loving CL.

Clin Vaccine Immunol. 2015 Oct;22(10):1109-20. doi: 10.1128/CVI.00358-15. Epub 2015 Aug 19.

Supplemental Content

Support Center